Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in Interest ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Amortizatization of Intangibles (2019 - 2023)

Marker Therapeutics (MRKR) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $153518.0 as the latest value for Q1 2023.

  • Quarterly Amortizatization of Intangibles fell 40.47% to $153518.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $786972.0 through Mar 2023, down 22.84% year-over-year, with the annual reading at $891343.0 for FY2022, 12.07% down from the prior year.
  • Amortizatization of Intangibles for Q1 2023 was $153518.0 at Marker Therapeutics, up from $151897.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $259170.0 in Q2 2022, with the low at $44211.0 in Q1 2019.
  • Average Amortizatization of Intangibles over 5 years is $166471.4, with a median of $222387.0 recorded in 2022.
  • The sharpest move saw Amortizatization of Intangibles skyrocketed 442.56% in 2020, then tumbled 40.59% in 2022.
  • Over 5 years, Amortizatization of Intangibles stood at $46540.0 in 2019, then surged by 442.56% to $252509.0 in 2020, then increased by 1.26% to $255697.0 in 2021, then crashed by 40.59% to $151897.0 in 2022, then rose by 1.07% to $153518.0 in 2023.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $153518.0, $151897.0, and $222387.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.